SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-22-005621
Filing Date
2022-01-10
Accepted
2022-01-10 16:02:28
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B4 d155225d424b4.htm 424B4 2429772
2 GRAPHIC g155225g11d11.jpg GRAPHIC 132129
3 GRAPHIC g155225g13a00.jpg GRAPHIC 122851
4 GRAPHIC g155225g22b30.jpg GRAPHIC 74160
5 GRAPHIC g155225g22z92.jpg GRAPHIC 112079
6 GRAPHIC g155225g23a23.jpg GRAPHIC 88202
7 GRAPHIC g155225g23s23.jpg GRAPHIC 109228
8 GRAPHIC g155225g24x25.jpg GRAPHIC 78108
9 GRAPHIC g155225g31v63.jpg GRAPHIC 80309
10 GRAPHIC g155225g36n42.jpg GRAPHIC 316344
11 GRAPHIC g155225g69i61.jpg GRAPHIC 129200
12 GRAPHIC g155225g80r72.jpg GRAPHIC 178075
13 GRAPHIC g155225g92x08.jpg GRAPHIC 44812
14 GRAPHIC g155225g96o04.jpg GRAPHIC 105570
  Complete submission text file 0001193125-22-005621.txt   4579690
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-261703 | Film No.: 22521269
SIC: 2834 Pharmaceutical Preparations